Back to Results
First PageMeta Content
Food and Drug Administration / Center for Drug Evaluation and Research / United States Department of Health and Human Services / Rintatolimod / Chronic Fatigue Syndrome Advisory Committee / Drug development / Off-label use / Pharmacology / Pharmaceutical sciences / Clinical research


Microsoft Word[removed]Stakeholder Teleconference Transcript.doc
Add to Reading List

Open Document

File Size: 238,83 KB

Share Result on Facebook

Country

United States / /

IndustryTerm

biological products / insurance / /

MedicalCondition

cancers / serious diseases / HIV / disease / certain diseases / different diseases / chronic fatigue syndrome / Allergy / myalgic encephalomyelitis / serious complex disease / Pulmonary / diseases / AIDS / pediatric cancers / illness / very rare diseases / /

Organization

office of Medical Policy / National Institute of Health / office of Executive Programs / Chronic Fatigue Syndrome Advisory Committee / office of New Drugs / Division of Anti-Viral Drugs / Center for Drugs / FDA's office of Legislation / CDER's office of Planning and Analysis / Division of Pulmonary / FDA CDER / FDA / Center for Drug and Evaluation Research / Center for Drug Evaluation and Research / Division of Pulmonology / Allergy and Rheumatology Products / /

Person

Robert Miller / Janet Woodcock / Alina Gonzalez / Ramesh Menon / Theresa Michele / Lydia Gilbert-McClain / Mary Gross / Keith Hull / Jerome Horowitz / Sandy Kweder / Andrea Tan / Janet Norden / Sandra Kweder / Randi Clark / /

Position

EST Coordinator / Clinical Team Leader / Coordinator / Policy Analyst / Deputy Director / Director for our Center / Project Manager / patient and patient advocate / physician / Deputy Division Director for the Division / Public Health Analyst / representative / Associate Director for Regulatory Affairs / /

Product

Valtrex / Vistide / Valcyte / versed / /

ProvinceOrState

Maine / /

Technology

drug development / /

SocialTag